Click here to register

Thermo Fisher Scientific is excited to announce an upcoming webinar titled "Supporting Efficacy and Scaling with a Next-Generation T Cell AOF Formulation Medium." This informative session will delve into the advancements in T-cell medium, featuring an innovative animal origin-free (AOF) formulation designed to enhance the therapeutic potential of cell therapies.

Webinar Details:

• Date: Wednesday, June 26, 2024
• Time: 14:00 SGT | 15:00 JST | 11:30 IST
• Registration Link: Click here to register

As the cell therapy industry continues to grow, there is an increasing demand for consistent, reproducible, and automated T-cell manufacturing processes. Thermo Fisher Scientific’s novel T-cell medium addresses these needs with its next-generation formulation, free from animal origins, ensuring enhanced safety and performance.

Why Attend?

• Discover Innovations: Learn about the latest advancements in T-cell medium formulations and how they can support the efficacy and scalability of your cell therapy processes.
• Enhance Therapeutic Potential: Understand the benefits of using an animal origin-free (AOF) formulation and how it can improve the consistency and reproducibility of T-cell manufacturing.
• Stay Ahead: Gain insights into the future of automated T-cell manufacturing and how these innovations can help you stay at the forefront of cell therapy development.